Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fangqi Deng
Observed name:
F Deng
Institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
Observed institutions:
Sun Yat-sen University,
Chinese PLA General Hospital,
Sixth Affiliated Hospital of Sun Yat-sen University,
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
ORCID:
0009-0002-7833-3406
Observed ORCID:
0009-0002-7833-3406
OpenAlex ID:
A5000801672
Combatting ageing in dermal papilla cells and promoting hair follicle regeneration using exosomes from human hair follicle dermal sheath cup cells
2023
·
Fang Liu
, Si Liu
, et al.
·
Experimental Dermatology
·
24
Body mass index, as a novel predictor of hepatocellular carcinoma patients treated with Anti-PD-1 immunotherapy
2022
·
Jierong Chen
, Lianghe Lu
, et al.
·
Frontiers in Medicine
·
15
PDF
Sirtuin 1, as a potential prognosis marker in clear cell renal cell carcinoma, regulates lipid metabolism and immune infiltration
2024
·
Xuefei Wang
, Fangqi Deng
, et al.
·
Biomolecules and Biomedicine
·
2
PDF
[Comparison of psychological distress and quality of life in patients with advanced liver cancer before and after transformation therapy].
2022
·
L Pan
, W Zhang
, et al.
·
PubMed
·
2
Evolution of genome and immunogenome in esophageal squamous cell carcinomas driven by neoadjuvant chemoradiotherapy
2024
·
Zelin Weng
, Zihang Mai
, et al.
·
International Journal of Cancer
·
1
PDF
Long‐Term Prognosis and Immunotranscriptomic Landscape in Esophageal Squamous Cell Carcinoma With Different Pathological Responses to Neoadjuvant Chemoradiotherapy: A Retrospective Cohort Study
2026
·
Jianye Yuan
, Zelin Weng
, et al.
·
MedComm – Oncology
Show more works
View as search
Works count:
6
Citation count:
44
H-index:
2
I10-index:
2
Year
Topic
Type